Biopharma company Xintela develops stem cell products with therapeutic properties aiming to treat diseases that currently lack effective treatment options. The company's stem cells stand out from others through a selection step in the production process that provides quality-assured, homogenous and pure stem cell preparations. BioStock talked to Lucienne Vonk, Director Musculoskeletal Diseases at Xintela, about the benefits of the company's stem cell products.